Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Meloxicam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for meloxicam?

Meloxicam is the generic ingredient in three branded drugs marketed by Taro, Aurobindo Pharma, Yung Shin Pharm, Breckenridge Pharm, Zydus Pharms Usa, Mylan, Roxane, Unichem, Strides Pharma, Cipla Ltd, Boehringer Ingelheim, Corepharma, Dr Reddys Labs Inc, Glenmark Generics, Iroko Pharms Llc, Yabao Pharm, Frontida Biopharm, Teva Pharms, Sun Pharm Inds Inc, Puracap Pharm, Cr Double Crane, Lupin Pharms, and Apotex Inc, and is included in twenty-five NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has twenty-nine patent family members in twenty-four countries.

There are twenty-two drug master file entries for meloxicam. Fifty-five suppliers are listed for this compound.

Summary for Generic Name: meloxicam

Tradenames:3
Patents:3
Applicants:23
NDAs:25
Drug Master File Entries: see list22
Suppliers / Packagers: see list55
Bulk Api Vendors: see list86
Clinical Trials: see list10
Patent Applications: see list7,989
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meloxicam at DailyMed

Pharmacology for Ingredient: meloxicam

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
MELOXICAM
meloxicam
TABLET;ORAL077937-002Jul 19, 2006RXNoNo► Subscribe► Subscribe
Puracap Pharm
MELOXICAM
meloxicam
TABLET;ORAL077938-001Jul 19, 2006RXNoNo► Subscribe► Subscribe
Zydus Pharms Usa
MELOXICAM
meloxicam
TABLET;ORAL077921-001Jul 19, 2006RXNoNo► Subscribe► Subscribe
Glenmark Generics
MELOXICAM
meloxicam
TABLET;ORAL077932-001Jul 19, 2006RXNoNo► Subscribe► Subscribe
Mylan
MELOXICAM
meloxicam
TABLET;ORAL077934-002Jul 20, 2006DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: meloxicam

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,682,747 Process for preparing an oral suspension of a pharmaceutical substance► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: meloxicam

Country Document Number Estimated Expiration
Colombia5070601► Subscribe
Portugal1066029► Subscribe
World Intellectual Property Organization (WIPO)9949845► Subscribe
Norway20004822► Subscribe
Spain2184428► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc